Infinity Pharmaceuticals Investor Relations Material

Infinity Pharmaceuticals Inc. is a biopharmaceutical company focused on developing innovative therapies for cancer. The company's research primarily targets the immune system to enhance the body's ability to fight cancer. Infinity’s lead drug candidates aim to treat various types of solid tumors by modulating key immune pathways and working in combination with other therapies to improve patient outcomes. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.